Cellular predictive factors of drug resistance in non-small cell lung carcinomas.
Volm
Manfred
M
Department of Oncological Diagnostics and Therapy, Central Unit of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Koomägi
Reet
R
Rittgen
Werner
W
D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D017209:Apoptosis; D015152:Blotting, Northern / Q000379:methods; D015139:Blotting, Southern / Q000379:methods; D015153:Blotting, Western / Q000379:methods; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism; D002455:Cell Division; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D008833:Microcirculation; D009363:Neoplasm Proteins; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D020394:Vault Ribonucleoprotein Particles; D000099187:Major Vault Protein
D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D009363:Neoplasm Proteins; D020394:Vault Ribonucleoprotein Particles; D000099187:Major Vault Protein